menu
    • menu

    Company profile for Theravance Biopharma

    NEW Drugs in Dev: 17
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Theravance Biopharma is a diversified biopharmaceutical company with the core purpose of creating medicines that make a difference in the lives of patients suffering from serious illness.Our pipeline of internally discovered product candidates includes potential best-in-class medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. VIBATIV® (telavancin), our fi...
    Theravance Biopharma is a diversified biopharmaceutical company with the core purpose of creating medicines that make a difference in the lives of patients suffering from serious illness.Our pipeline of internally discovered product candidates includes potential best-in-class medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting. VIBATIV® (telavancin), our first commercial product, is a once-daily dual-mechanism antibiotic approved in the U.S., Europe and certain other countries for certain difficult-to-treat infections.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Theravance BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    901 Gateway Boulevard South San Francisco, CA 94080
    Telephone
    Telephone
    650-808-6000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.theravance.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail
    Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail

    04 Mar 2026

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    04 Mar 2026
    Share Share
    Theravance Biopharma Misses Phase 3 CYPRESS Goal, Cuts Costs
    Theravance Biopharma Misses Phase 3 CYPRESS Goal, Cuts Costs

    03 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-reports-phase-3-cypress-study-did-not-meet-primary-endpoint-board-accelerates-strategic-review-and-announces-cost-reduction-actions-302702475.html

    PR NEWSWIRE
    03 Mar 2026
    Share Share
    Theravance Bio To Host Virtual Investor Event On Ampreloxetine
    Theravance Bio To Host Virtual Investor Event On Ampreloxetine

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-host-virtual-kol-investor-event-to-review-ampreloxetine-phase-3-clinical-development-program-ahead-of-topline-data-in-q1-2026-on-december-8-2025-302621860.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    Theravance Bio To Join Investor Conferences
    Theravance Bio To Join Investor Conferences

    19 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-participate-in-upcoming-investor-conferences-302619765.html

    PR NEWSWIRE
    19 Nov 2025
    Share Share
    Theravance Bio Reports Q3 2025 Financials & Corporate Update
    Theravance Bio Reports Q3 2025 Financials & Corporate Update

    11 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-inc-reports-third-quarter-2025-financial-results-and-provides-corporate-update-302610645.html

    PR NEWSWIRE
    11 Nov 2025
    Share Share
    Theravance Bio to Share Ampreloxetine Data at Symposium
    Theravance Bio to Share Ampreloxetine Data at Symposium

    29 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-to-present-data-on-ampreloxetine-at-the-36th-international-symposium-on-the-autonomic-nervous-system-302597901.html

    PR NEWSWIRE
    29 Oct 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search